ESIKA description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

ESIKA

Ventura Corporation (San Juan, P.R)

ēsika Hydro-Nutritive Foundation SPF 13


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

Drug Facts

Active Ingredients

Octinoxate (5%), Oxybenzone (2%)

Purpose

Sunscreen

ESIKA Uses

  • Helps prevent sunburn.
  • Higher SPF gives more sunburn protection.
  • Provides moderate protection against sunburn.

Warnings

  • For external use only
  • When using this product keep out of eyes. Rinse with water to remove.
  • Stop use and ask a doctor if rash and irritation develops and lasts.
  • Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

  • Apply smootly every morning before sun exposure and as needed.
  • Apply to the forehead, nose, chin and both cheeks. Blend with circular motion and spread softly.
  • Moderate sun protection product.

ESIKA Other information

  • Sun alert: Limiting sun exposure, wearing protective clothing, and using sunscreens may reduce the risk of skin aging, skin cancer, and other harmful effects of the sun.

Inactive ingredients

Aqua (water), cyclomethicone, cyclopentasiloxane, talc, cetyl peg/ppg-10/1 dimethicone, polyglyceryl-4 isostearate, pisum sativum (pea) extract), peg-12 dimethicone crosspolymer, hexyl laurate, isostearyl neopentanoate, disteardimonium hectorite, cyclohexasiloxane, rosa centifolia flower water, sodium chloride, mannitol, dimethicone, propylene carbonate, propylene glycol, phenoxyethanol, octyldodecanol, butylene glycol, dimethiconol, methylparaben, propylparaben, cetearyl dimethicone crosspolymer, tocopheryl acetate, microcristallina cera (microcrystalline wax), methicone, polymethylsilsesquioxane, petrolatum, phospholipids, bha, bht, cyclodextrin, butylparaben, ethylparaben, cholesterol, faex extract (yeast extract), isobutylparaben, candelilla cera (euphorbia cerifera (candelilla) wax), cera alba (beeswax), cetearyl alcohol, cetearyl glucoside, copernicia cerifera cera (copernicia cerifera (carnauba) wax), polyglyceryl-2 dipolyhydroxystearate, olea europaea oil unsaponifiables (olea europaea (olive) oil unsaponifiables), glycosphingolipids, disodium succinate. May contain: CI 77891 (titanium dioxide), CI 77492 (iron oxides), CI 77491 (iron oxides), CI 77499 (iron oxides).

PRINCIPAL DISPLAY PANEL - 30 ml Carton - Beige 1

ēsika

Hydro-Nutritive
Foundation
SPF 13

30 ml e (1 fl.oz.)

ESIKA

PRINCIPAL DISPLAY PANEL - 30 ml Carton - Beige 2

ēsika

Hydro-Nutritive
Foundation
SPF 13

30 ml e (1 fl.oz.)

ESIKA

PRINCIPAL DISPLAY PANEL - 30 ml Carton - Beige 3

ēsika

Hydro-Nutritive
Foundation
SPF 13

30 ml e (1 fl.oz.)

ESIKA

PRINCIPAL DISPLAY PANEL - 30 ml Carton - Beige 4

ēsika

Hydro-Nutritive
Foundation
SPF 13

30 ml e (1 fl.oz.)

ESIKA

PRINCIPAL DISPLAY PANEL - 30 ml Carton - Beige 5

ēsika

Hydro-Nutritive
Foundation
SPF 13

30 ml e (1 fl.oz.)

ESIKA

PRINCIPAL DISPLAY PANEL - 30 ml Carton - Beige 6

ēsika

Hydro-Nutritive
Foundation
SPF 13

30 ml e (1 fl.oz.)

ESIKA

PRINCIPAL DISPLAY PANEL - 30 ml Carton - Rosa 1

ēsika

Hydro-Nutritive
Foundation
SPF 13

30 ml e (1 fl.oz.)

ESIKA

PRINCIPAL DISPLAY PANEL - 30 ml Carton - Rosa 2

ēsika

Hydro-Nutritive
Foundation
SPF 13

30 ml e (1 fl.oz.)

ESIKA

PRINCIPAL DISPLAY PANEL - 30 ml Carton - Rosa 3

ēsika

Hydro-Nutritive
Foundation
SPF 13

30 ml e (1 fl.oz.)

ESIKA

PRINCIPAL DISPLAY PANEL - 30 ml Carton - Rosa 4

ēsika

Hydro-Nutritive
Foundation
SPF 13

30 ml e (1 fl.oz.)

ESIKA

PRINCIPAL DISPLAY PANEL - 30 ml Carton - Rosa 5

ēsika

Hydro-Nutritive
Foundation
SPF 13

30 ml e (1 fl.oz.)

ESIKA

PRINCIPAL DISPLAY PANEL - 30 ml Carton - Rosa 6

ēsika

Hydro-Nutritive
Foundation
SPF 13

30 ml e (1 fl.oz.)

ESIKA

ESIKA

Octinoxate and Oxybenzone LOTION

Product Information

Product Type Human otc drug label Item Code (Source) NDC:13537-305
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 0.05 mg
OXYBENZONE OXYBENZONE 0.02 mg

Inactive Ingredients

Ingredient Name Strength
water
cyclomethicone
CYCLOMETHICONE 5
talc
POLYGLYCERYL-4 ISOSTEARATE
PEA
HEXYL LAURATE
CYCLOMETHICONE 6
ROSA CENTIFOLIA FLOWER OIL
SODIUM CHLORIDE
mannitol
DIMETHICONE
PROPYLENE CARBONATE
propylene glycol
PHENOXYETHANOL
OCTYLDODECANOL
BUTYLENE GLYCOL
METHYLPARABEN
PROPYLPARABEN
MICROCRYSTALLINE WAX
petrolatum
BUTYLATED HYDROXYANISOLE
BUTYLATED HYDROXYTOLUENE
BUTYLPARABEN
ETHYLPARABEN
CHOLESTEROL
yeast
isobutylparaben
CANDELILLA WAX
YELLOW WAX
CETOSTEARYL ALCOHOL
CETEARYL GLUCOSIDE
carnauba wax
olive oil
sodium succinate anhydrous
titanium dioxide
FERRIC OXIDE YELLOW
ferric oxide red
FERROSOFERRIC OXIDE

Product Characteristics

Color
BROWN (Beige 1)

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:13537-305-01 30 in 1 BOTTLE
2 NDC:13537-305-02 1 in 1 BOX

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2011-05-17


ESIKA

Octinoxate and Oxybenzone LOTION

Product Information

Product Type Human otc drug label Item Code (Source) NDC:13537-306
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 0.05 mg
OXYBENZONE OXYBENZONE 0.02 mg

Inactive Ingredients

Ingredient Name Strength
water
cyclomethicone
CYCLOMETHICONE 5
talc
POLYGLYCERYL-4 ISOSTEARATE
PEA
HEXYL LAURATE
CYCLOMETHICONE 6
ROSA CENTIFOLIA FLOWER OIL
SODIUM CHLORIDE
mannitol
DIMETHICONE
PROPYLENE CARBONATE
propylene glycol
PHENOXYETHANOL
OCTYLDODECANOL
BUTYLENE GLYCOL
METHYLPARABEN
PROPYLPARABEN
MICROCRYSTALLINE WAX
petrolatum
BUTYLATED HYDROXYANISOLE
BUTYLATED HYDROXYTOLUENE
BUTYLPARABEN
ETHYLPARABEN
CHOLESTEROL
yeast
isobutylparaben
CANDELILLA WAX
YELLOW WAX
CETOSTEARYL ALCOHOL
CETEARYL GLUCOSIDE
carnauba wax
olive oil
sodium succinate anhydrous
titanium dioxide
FERRIC OXIDE YELLOW
ferric oxide red
FERROSOFERRIC OXIDE

Product Characteristics

Color
BROWN (Beige 2)

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:13537-306-01 30 in 1 BOTTLE
2 NDC:13537-306-02 1 in 1 BOX

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2011-05-17


ESIKA

Octinoxate and Oxybenzone LOTION

Product Information

Product Type Human otc drug label Item Code (Source) NDC:13537-307
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 0.05 mg
OXYBENZONE OXYBENZONE 0.02 mg

Inactive Ingredients

Ingredient Name Strength
water
cyclomethicone
CYCLOMETHICONE 5
talc
POLYGLYCERYL-4 ISOSTEARATE
PEA
HEXYL LAURATE
CYCLOMETHICONE 6
ROSA CENTIFOLIA FLOWER OIL
SODIUM CHLORIDE
mannitol
DIMETHICONE
PROPYLENE CARBONATE
propylene glycol
PHENOXYETHANOL
OCTYLDODECANOL
BUTYLENE GLYCOL
METHYLPARABEN
PROPYLPARABEN
MICROCRYSTALLINE WAX
petrolatum
BUTYLATED HYDROXYANISOLE
BUTYLATED HYDROXYTOLUENE
BUTYLPARABEN
ETHYLPARABEN
CHOLESTEROL
yeast
isobutylparaben
CANDELILLA WAX
YELLOW WAX
CETOSTEARYL ALCOHOL
CETEARYL GLUCOSIDE
carnauba wax
olive oil
sodium succinate anhydrous
titanium dioxide
FERRIC OXIDE YELLOW
ferric oxide red
FERROSOFERRIC OXIDE

Product Characteristics

Color
BROWN (Beige 3)

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:13537-307-01 30 in 1 BOTTLE
2 NDC:13537-307-02 1 in 1 BOX

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2011-05-17


ESIKA

Octinoxate and Oxybenzone LOTION

Product Information

Product Type Human otc drug label Item Code (Source) NDC:13537-308
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 0.05 mg
OXYBENZONE OXYBENZONE 0.02 mg

Inactive Ingredients

Ingredient Name Strength
water
cyclomethicone
CYCLOMETHICONE 5
talc
POLYGLYCERYL-4 ISOSTEARATE
PEA
HEXYL LAURATE
CYCLOMETHICONE 6
ROSA CENTIFOLIA FLOWER OIL
SODIUM CHLORIDE
mannitol
DIMETHICONE
PROPYLENE CARBONATE
propylene glycol
PHENOXYETHANOL
OCTYLDODECANOL
BUTYLENE GLYCOL
METHYLPARABEN
PROPYLPARABEN
MICROCRYSTALLINE WAX
petrolatum
BUTYLATED HYDROXYANISOLE
BUTYLATED HYDROXYTOLUENE
BUTYLPARABEN
ETHYLPARABEN
CHOLESTEROL
yeast
isobutylparaben
CANDELILLA WAX
YELLOW WAX
CETOSTEARYL ALCOHOL
CETEARYL GLUCOSIDE
carnauba wax
olive oil
sodium succinate anhydrous
titanium dioxide
FERRIC OXIDE YELLOW
ferric oxide red
FERROSOFERRIC OXIDE

Product Characteristics

Color
BROWN (Beige 4)

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:13537-308-01 30 in 1 BOTTLE
2 NDC:13537-308-02 1 in 1 BOX

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2011-05-17


ESIKA

Octinoxate and Oxybenzone LOTION

Product Information

Product Type Human otc drug label Item Code (Source) NDC:13537-309
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 0.05 mg
OXYBENZONE OXYBENZONE 0.02 mg

Inactive Ingredients

Ingredient Name Strength
water
cyclomethicone
CYCLOMETHICONE 5
talc
POLYGLYCERYL-4 ISOSTEARATE
PEA
HEXYL LAURATE
CYCLOMETHICONE 6
ROSA CENTIFOLIA FLOWER OIL
SODIUM CHLORIDE
mannitol
DIMETHICONE
PROPYLENE CARBONATE
propylene glycol
PHENOXYETHANOL
OCTYLDODECANOL
BUTYLENE GLYCOL
METHYLPARABEN
PROPYLPARABEN
MICROCRYSTALLINE WAX
petrolatum
BUTYLATED HYDROXYANISOLE
BUTYLATED HYDROXYTOLUENE
BUTYLPARABEN
ETHYLPARABEN
CHOLESTEROL
yeast
isobutylparaben
CANDELILLA WAX
YELLOW WAX
CETOSTEARYL ALCOHOL
CETEARYL GLUCOSIDE
carnauba wax
olive oil
sodium succinate anhydrous
titanium dioxide
FERRIC OXIDE YELLOW
ferric oxide red
FERROSOFERRIC OXIDE

Product Characteristics

Color
BROWN (Beige 5)

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:13537-309-01 30 in 1 BOTTLE
2 NDC:13537-309-02 1 in 1 BOX

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2011-05-17


ESIKA

Octinoxate and Oxybenzone LOTION

Product Information

Product Type Human otc drug label Item Code (Source) NDC:13537-310
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 0.05 mg
OXYBENZONE OXYBENZONE 0.02 mg

Inactive Ingredients

Ingredient Name Strength
water
cyclomethicone
CYCLOMETHICONE 5
talc
POLYGLYCERYL-4 ISOSTEARATE
PEA
HEXYL LAURATE
CYCLOMETHICONE 6
ROSA CENTIFOLIA FLOWER OIL
SODIUM CHLORIDE
mannitol
DIMETHICONE
PROPYLENE CARBONATE
propylene glycol
PHENOXYETHANOL
OCTYLDODECANOL
BUTYLENE GLYCOL
METHYLPARABEN
PROPYLPARABEN
MICROCRYSTALLINE WAX
petrolatum
BUTYLATED HYDROXYANISOLE
BUTYLATED HYDROXYTOLUENE
BUTYLPARABEN
ETHYLPARABEN
CHOLESTEROL
yeast
isobutylparaben
CANDELILLA WAX
YELLOW WAX
CETOSTEARYL ALCOHOL
CETEARYL GLUCOSIDE
carnauba wax
olive oil
sodium succinate anhydrous
titanium dioxide
FERRIC OXIDE YELLOW
ferric oxide red
FERROSOFERRIC OXIDE

Product Characteristics

Color
BROWN (Beige 6)

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:13537-310-01 30 in 1 BOTTLE
2 NDC:13537-310-02 1 in 1 BOX

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2011-05-17


ESIKA

Octinoxate and Oxybenzone LOTION

Product Information

Product Type Human otc drug label Item Code (Source) NDC:13537-311
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 0.05 mg
OXYBENZONE OXYBENZONE 0.02 mg

Inactive Ingredients

Ingredient Name Strength
water
cyclomethicone
CYCLOMETHICONE 5
talc
POLYGLYCERYL-4 ISOSTEARATE
PEA
HEXYL LAURATE
CYCLOMETHICONE 6
ROSA CENTIFOLIA FLOWER OIL
SODIUM CHLORIDE
mannitol
DIMETHICONE
PROPYLENE CARBONATE
propylene glycol
PHENOXYETHANOL
OCTYLDODECANOL
BUTYLENE GLYCOL
METHYLPARABEN
PROPYLPARABEN
MICROCRYSTALLINE WAX
petrolatum
BUTYLATED HYDROXYANISOLE
BUTYLATED HYDROXYTOLUENE
BUTYLPARABEN
ETHYLPARABEN
CHOLESTEROL
yeast
isobutylparaben
CANDELILLA WAX
YELLOW WAX
CETOSTEARYL ALCOHOL
CETEARYL GLUCOSIDE
carnauba wax
olive oil
sodium succinate anhydrous
titanium dioxide
FERRIC OXIDE YELLOW
ferric oxide red
FERROSOFERRIC OXIDE

Product Characteristics

Color
RED (Rosa 1)

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:13537-311-01 30 in 1 BOTTLE
2 NDC:13537-311-02 1 in 1 BOX

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2011-05-17


ESIKA

Octinoxate and Oxybenzone LOTION

Product Information

Product Type Human otc drug label Item Code (Source) NDC:13537-312
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 0.05 mg
OXYBENZONE OXYBENZONE 0.02 mg

Inactive Ingredients

Ingredient Name Strength
water
cyclomethicone
CYCLOMETHICONE 5
talc
POLYGLYCERYL-4 ISOSTEARATE
PEA
HEXYL LAURATE
CYCLOMETHICONE 6
ROSA CENTIFOLIA FLOWER OIL
SODIUM CHLORIDE
mannitol
DIMETHICONE
PROPYLENE CARBONATE
propylene glycol
PHENOXYETHANOL
OCTYLDODECANOL
BUTYLENE GLYCOL
METHYLPARABEN
PROPYLPARABEN
MICROCRYSTALLINE WAX
petrolatum
BUTYLATED HYDROXYANISOLE
BUTYLATED HYDROXYTOLUENE
BUTYLPARABEN
ETHYLPARABEN
CHOLESTEROL
yeast
isobutylparaben
CANDELILLA WAX
YELLOW WAX
CETOSTEARYL ALCOHOL
CETEARYL GLUCOSIDE
carnauba wax
olive oil
sodium succinate anhydrous
titanium dioxide
FERRIC OXIDE YELLOW
ferric oxide red
FERROSOFERRIC OXIDE

Product Characteristics

Color
RED (Rosa 2)

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:13537-312-01 30 in 1 BOTTLE
2 NDC:13537-312-02 1 in 1 BOX

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2011-05-17


ESIKA

Octinoxate and Oxybenzone LOTION

Product Information

Product Type Human otc drug label Item Code (Source) NDC:13537-313
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 0.05 mg
OXYBENZONE OXYBENZONE 0.02 mg

Inactive Ingredients

Ingredient Name Strength
water
cyclomethicone
CYCLOMETHICONE 5
talc
POLYGLYCERYL-4 ISOSTEARATE
PEA
HEXYL LAURATE
CYCLOMETHICONE 6
ROSA CENTIFOLIA FLOWER OIL
SODIUM CHLORIDE
mannitol
DIMETHICONE
PROPYLENE CARBONATE
propylene glycol
PHENOXYETHANOL
OCTYLDODECANOL
BUTYLENE GLYCOL
METHYLPARABEN
PROPYLPARABEN
MICROCRYSTALLINE WAX
petrolatum
BUTYLATED HYDROXYANISOLE
BUTYLATED HYDROXYTOLUENE
BUTYLPARABEN
ETHYLPARABEN
CHOLESTEROL
yeast
isobutylparaben
CANDELILLA WAX
YELLOW WAX
CETOSTEARYL ALCOHOL
CETEARYL GLUCOSIDE
carnauba wax
olive oil
sodium succinate anhydrous
titanium dioxide
FERRIC OXIDE YELLOW
ferric oxide red
FERROSOFERRIC OXIDE

Product Characteristics

Color
RED (Rosa 3)

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:13537-313-01 30 in 1 BOTTLE
2 NDC:13537-313-02 1 in 1 BOX

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2011-05-17


ESIKA

Octinoxate and Oxybenzone LOTION

Product Information

Product Type Human otc drug label Item Code (Source) NDC:13537-314
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 0.05 mg
OXYBENZONE OXYBENZONE 0.02 mg

Inactive Ingredients

Ingredient Name Strength
water
cyclomethicone
CYCLOMETHICONE 5
talc
POLYGLYCERYL-4 ISOSTEARATE
PEA
HEXYL LAURATE
CYCLOMETHICONE 6
ROSA CENTIFOLIA FLOWER OIL
SODIUM CHLORIDE
mannitol
DIMETHICONE
PROPYLENE CARBONATE
propylene glycol
PHENOXYETHANOL
OCTYLDODECANOL
BUTYLENE GLYCOL
METHYLPARABEN
PROPYLPARABEN
MICROCRYSTALLINE WAX
petrolatum
BUTYLATED HYDROXYANISOLE
BUTYLATED HYDROXYTOLUENE
BUTYLPARABEN
ETHYLPARABEN
CHOLESTEROL
yeast
isobutylparaben
CANDELILLA WAX
YELLOW WAX
CETOSTEARYL ALCOHOL
CETEARYL GLUCOSIDE
carnauba wax
olive oil
sodium succinate anhydrous
titanium dioxide
FERRIC OXIDE YELLOW
ferric oxide red
FERROSOFERRIC OXIDE

Product Characteristics

Color
RED (Rosa 4)

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:13537-314-01 30 in 1 BOTTLE
2 NDC:13537-314-02 1 in 1 BOX

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2011-05-17


ESIKA

Octinoxate and Oxybenzone LOTION

Product Information

Product Type Human otc drug label Item Code (Source) NDC:13537-315
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 0.05 mg
OXYBENZONE OXYBENZONE 0.02 mg

Inactive Ingredients

Ingredient Name Strength
water
cyclomethicone
CYCLOMETHICONE 5
talc
POLYGLYCERYL-4 ISOSTEARATE
PEA
HEXYL LAURATE
CYCLOMETHICONE 6
ROSA CENTIFOLIA FLOWER OIL
SODIUM CHLORIDE
mannitol
DIMETHICONE
PROPYLENE CARBONATE
propylene glycol
PHENOXYETHANOL
OCTYLDODECANOL
BUTYLENE GLYCOL
METHYLPARABEN
PROPYLPARABEN
MICROCRYSTALLINE WAX
petrolatum
BUTYLATED HYDROXYANISOLE
BUTYLATED HYDROXYTOLUENE
BUTYLPARABEN
ETHYLPARABEN
CHOLESTEROL
yeast
isobutylparaben
CANDELILLA WAX
YELLOW WAX
CETOSTEARYL ALCOHOL
CETEARYL GLUCOSIDE
carnauba wax
olive oil
sodium succinate anhydrous
titanium dioxide
FERRIC OXIDE YELLOW
ferric oxide red
FERROSOFERRIC OXIDE

Product Characteristics

Color
RED (Rosa 5)

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:13537-315-01 30 in 1 BOTTLE
2 NDC:13537-315-02 1 in 1 BOX

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2011-05-17


ESIKA

Octinoxate and Oxybenzone LOTION

Product Information

Product Type Human otc drug label Item Code (Source) NDC:13537-316
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 0.05 mg
OXYBENZONE OXYBENZONE 0.02 mg

Inactive Ingredients

Ingredient Name Strength
water
cyclomethicone
CYCLOMETHICONE 5
talc
POLYGLYCERYL-4 ISOSTEARATE
PEA
HEXYL LAURATE
CYCLOMETHICONE 6
ROSA CENTIFOLIA FLOWER OIL
SODIUM CHLORIDE
mannitol
DIMETHICONE
PROPYLENE CARBONATE
propylene glycol
PHENOXYETHANOL
OCTYLDODECANOL
BUTYLENE GLYCOL
METHYLPARABEN
PROPYLPARABEN
MICROCRYSTALLINE WAX
petrolatum
BUTYLATED HYDROXYANISOLE
BUTYLATED HYDROXYTOLUENE
BUTYLPARABEN
ETHYLPARABEN
CHOLESTEROL
yeast
isobutylparaben
CANDELILLA WAX
YELLOW WAX
CETOSTEARYL ALCOHOL
CETEARYL GLUCOSIDE
carnauba wax
olive oil
sodium succinate anhydrous
titanium dioxide
FERRIC OXIDE YELLOW
ferric oxide red
FERROSOFERRIC OXIDE

Product Characteristics

Color
RED (Rosa 6)

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:13537-316-01 30 in 1 BOTTLE
2 NDC:13537-316-02 1 in 1 BOX

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2011-05-17


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.